Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

Recruiting

Phase 3

Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryAnticoagulation in ICH Survivors for Stroke Prevention and Recovery

Sponsor:

Yale University

Code:

NCT03907046

Conditions

Intracerebral Hemorrhage

Atrial Fibrillation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Apixaban

Aspirin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Yale University on 2025-03-25.